Sigma Healthcare Limited (ASX: SIG) - Share Price
Current share price for SIG : $2.800 0.03 (1.08%)+
Sigma Healthcare Limited (SIG), an ASX-listed company, is an Australian retail pharmacy franchisor and full line pharmaceutical wholesale and distributor to community pharmacies. From modest beginnings in Melbourne in FY1912, the company has grown into a vibrant, nationwide network servicing community pharmacy.
SIG General Information +
| ASX Code | SIG |
| Website | N/A |
| Industry/Sector | Health Care Distributors |
| Market Cap ($M) | 32,322 |
| SIG Share Price | $2.800 |
| Day High | $2.800 |
| Day Low | $2.760 |
| Last Close | $2.800 |
| SIG Share Price Movement | - ( No change ) |
Prices as at 16:40, 29 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Sigma Healthcare Limited (SIG) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | 2¢ | 100% | 4 Mar 2026 | 20 Mar 2026 | - | - | - |
| HFResult | 1.3¢ | 100% | 2 Sep 2025 | 18 Sep 2025 | - | - | - |
| Result | 0.5¢ | 0% | 1 Oct 2024 | 17 Oct 2024 | - | - | - |
See all dividends from Sigma Healthcare Limited (SIG) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Sigma Healthcare Limited (SIG) price-sensitive announcements
SIG - Withdrawal from Boots sale process
Sigma Healthcare Limited announced its withdrawal from the Boots sale process after determ
Sigma Healthcare Limited (SIG)
15 Jun 2026 | 9:13 AM
15 Jun 2026 | 9:13 AM
SIG - Macquarie Australia Conference 2026 - Update
Sigma Healthcare Limited announced its participation in the 2026 Macquarie Australia Confe
Sigma Healthcare Limited (SIG)
4 May 2026 | 5:13 PM
4 May 2026 | 5:13 PM
SIG - Sigma Half Year Results ASX Release
Sigma Healthcare Limited reported strong financial performance for the half year ending 31
Sigma Healthcare Limited (SIG)
26 Feb 2026 | 8:24 AM
26 Feb 2026 | 8:24 AM
SIG - Sigma Half Year Results Presentation
Sigma Healthcare Limited reported strong financial performance for the first half of FY26,
Sigma Healthcare Limited (SIG)
26 Feb 2026 | 8:24 AM
26 Feb 2026 | 8:24 AM
Sigma Healthcare Limited (SIG) Recent ASX Announcements
SIG Financial Summary
| Year to Jan | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026F | $295.73 | $2.56 | 806.60% | 110.55 | 1.41 | 0.50% | 100.0% |
| 2025F | $32.62 | $0.28 | -38.50% | 1,010.71 | 0.16 | 0.06% | 100.0% |
| 2024A | $4.88 | $0.46 | -67.40% | 159.03 | 1.00 | 1.37% | 100.0% |
SIG Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | ||
| EBOS Group Limited (EBO) | $3,468M | -0.1796 | -0.1002 | 0.1128 | 13.5259 | 15.0314 | 13.5074 | 6.46% | 4.65% | 5.17% |
| Sigma Healthcare Limited (SIG) | $31,976M | 15.7941 | 0.0893 | 0.1688 | 48.5114 | 44.5338 | 38.1018 | 0.65% | 1.17% | 1.53% |
SIG Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Vikesh Ramsunder | Chief Executive Officer, Managing Director | 17 Feb 2022 |
| Ms Danielle Di Pilla | Executive Director | 12 Feb 2025 |
| Mr Mario Verrocchi | Executive Director | 12 Feb 2025 |
| Mr Damien Gance | Executive Director | 12 Feb 2025 |
| Dr Christopher Graham Roberts | Non-Executive Director | 6 Oct 2023 |
| Mr Neville Mitchell | Non-Executive Director | 2 Feb 2023 |
| Ms Annette May Carey | Non-Executive Director | 1 Apr 2023 |
| Mr Jack Gance | Non-Executive Director | 12 Feb 2025 |
| Mr Michael Sammells | Non-Executive Director, Non-Executive Chairman | 1 Feb 2020 |
Sigma Healthcare Limited (SIG) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 10 Nov 2025 | CAREY, Annette | Buy | Indirect Shares | 10,000 | $3.124 | $31,237.440 |
| 28 Aug 2025 | GANCE, Jack | Sell | Indirect Shares | 155,103,420 | $3.100 | $480,820,602.000 |
| 29 May 2025 | PILLA, Danielle Di | Sell | Direct Shares | 7,342,150 | $3.175 | $23,312,794.680 |
See all changes in directors' interest & trades for Sigma Healthcare Limited (SIG) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
SIG Management
| Name | Position |
|---|---|
| Kara McGowan | General Counsel,Company Secretary |
| Mr M Conway | Chief Financial Officer |
SIG Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Sigma Healthcare Limited (SIG). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 2,555,284,920 (22.13%) | Mario Verrocchi |
| 1,579,050,058 (13.67%) | Jack Gance |
| 1,446,864,015 (12.53%) | Sam Gance |
SIG Calendar of Events
| Date | Event |
|---|---|
| 25 February 2027 | Report (Interim) |
| 16 September 2026 | Report (Annual) |
| 26 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
